Analyst reports

Through BostonGene, we are utilizing multiparametric discovery and big data analytics to uncover and validate biomarkers of therapeutic response.

We look forward to using BostonGene’s technology to facilitate our work in mechanisms of cancer neoantigen recognition.

Together, we are working to identify novel biomarkers and develop next-generation therapies fora true personalized approach to cancer care.

A tumor ‘‘personality’’ test: the BostonGene Tumor Portrait serves as a roadmap to guide treatment decision-making.

Through this collaboration we look forward to utilizing data and AI to gain more insights into the biology and mechanisms of investigational therapies at the earliest stages. These data will help us to better understand their potential in certain patient populations and ultimately help advance oncology medicines for patients who need them.

BostonGene's integrated analytic and AI capabilities will provide us with crucial insights towards developing breakthrough cancer treatments.

Collaborating with BostonGene allows us to apply advanced omnimodal analytics to real-world clinical challenges. By integrating genomic, transcriptomic and immune data into a unified platform, we can identify the right patients for the right trials, uncover novel biomarkers...